X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (157) 157
humans (94) 94
benzenesulfonates - chemistry (67) 67
environmental sciences (56) 56
niacinamide - analogs & derivatives (50) 50
phenylurea compounds (50) 50
animals (47) 47
benzenesulfonates - therapeutic use (43) 43
analysis (41) 41
benzenesulfonates (39) 39
pyridines - therapeutic use (37) 37
biotechnology & applied microbiology (34) 34
dyes (33) 33
adsorption (30) 30
degradation (30) 30
antineoplastic agents - therapeutic use (29) 29
benzenesulfonates - metabolism (29) 29
cancer (29) 29
kinetics (29) 29
azo compounds - chemistry (28) 28
food science & technology (28) 28
microbiology (28) 28
benzenesulfonates - economics (27) 27
female (27) 27
male (26) 26
pyridines - economics (25) 25
benzenesulfonates - toxicity (24) 24
biodegradation, environmental (24) 24
biodegradation (23) 23
removal (23) 23
antineoplastic agents - economics (21) 21
environment (21) 21
benzenesulfonates - analysis (20) 20
carcinoma, hepatocellular - drug therapy (20) 20
cost-benefit analysis (20) 20
liver neoplasms - drug therapy (20) 20
middle aged (20) 20
sorafenib (20) 20
hydrogen-ion concentration (19) 19
kidney neoplasms - drug therapy (19) 19
carcinoma, renal cell - drug therapy (18) 18
methods (18) 18
water pollutants, chemical - chemistry (18) 18
adult (17) 17
benzenesulfonates - pharmacology (17) 17
environment, general (17) 17
research (17) 17
atmospheric protection/air quality control/air pollution (16) 16
azo compounds (16) 16
chemistry, applied (16) 16
coloring agents - chemistry (16) 16
ecotoxicology (16) 16
identification (16) 16
oxidation (16) 16
oxidation-reduction (16) 16
time factors (16) 16
waste water technology / water pollution control / water management / aquatic pollution (16) 16
water purification - methods (16) 16
aqueous-solutions (15) 15
chemical properties (15) 15
environmental health (15) 15
oncology (15) 15
toxicology (15) 15
water (15) 15
chemistry (14) 14
environmental chemistry (14) 14
surface active agents (14) 14
aged (13) 13
bacteria (13) 13
benzenesulfonates - adverse effects (13) 13
decolorization (13) 13
studies (13) 13
surfactants (13) 13
usage (13) 13
benzenesulfonates - administration & dosage (12) 12
liver cancer (12) 12
pharmacology & pharmacy (12) 12
temperature (12) 12
treatment outcome (12) 12
waste-water (12) 12
acid orange 7 (11) 11
azo compounds - analysis (11) 11
azo compounds - metabolism (11) 11
azo dyes (11) 11
biochemistry & molecular biology (11) 11
carbon (11) 11
care and treatment (11) 11
engineering, environmental (11) 11
indoles - therapeutic use (11) 11
iron - chemistry (11) 11
pyridines - adverse effects (11) 11
pyrroles - therapeutic use (11) 11
spectroscopy, fourier transform infrared (11) 11
survival (11) 11
toxicity (11) 11
antimitotic agents (10) 10
antineoplastic agents (10) 10
bevacizumab (10) 10
farbstoff (10) 10
gastroenterology & hepatology (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Health Technology Assessment, ISSN 1366-5278, 01/2010, Volume 14, Issue 2, pp. 1 - 184
Objectives: To assess the clinical effectiveness and cost-effectiveness of bevacizumab, combined with interferon (IFN), sorafenib tosylate, sunitinib and... 
PHASE-III TRIAL | TARGETED THERAPY | 1ST-LINE TREATMENT | COST-EFFECTIVENESS | PROGRESSION-FREE SURVIVAL | HEALTH CARE SCIENCES & SERVICES | QUALITY-OF-LIFE | INTERFERON-ALPHA IFN | RANDOMIZED DISCONTINUATION TRIAL | HIGH-DOSE INTERLEUKIN-2 | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Benzenesulfonates - economics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Indoles - administration & dosage | Benzenesulfonates - adverse effects | Bevacizumab | Antibodies, Monoclonal, Humanized | Pyridines - adverse effects | Pyrroles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - economics | Pyrroles - adverse effects | Sirolimus - economics | Pyrroles - economics | Indoles - economics | Carcinoma, Renal Cell - drug therapy | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Pyridines - administration & dosage | Carcinoma, Renal Cell - pathology | Kidney Neoplasms - economics | Sirolimus - administration & dosage | Indoles - adverse effects | Carcinoma, Renal Cell - economics | Antibodies, Monoclonal - administration & dosage | Cost-Benefit Analysis | Kidney Neoplasms - enzymology | Pyridines - economics | Kidney Neoplasms - pathology | Kidney Neoplasms - drug therapy | Antibodies, Monoclonal - economics
Journal Article
BJU International, ISSN 1464-4096, 09/2011, Volume 108, Issue 5, pp. 665 - 672
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198137
..., Writing – original draft, Writing – review & editing * E-mail: maximilian.praeger@helmholtz-muenchen.de Affiliation: Institute of Health Economics and Health Care... 
RE-EXCISION | THERAPY | LOCAL RECURRENCE | BEVACIZUMAB | CONSERVATION SURGERY | MULTIDISCIPLINARY SCIENCES | RISK | POSITIVE MARGINS | BREAST-CONSERVING SURGERY | CANCER SURGERY | ENDOTHELIAL GROWTH-FACTOR | Breast Neoplasms - surgery | Breast Neoplasms - economics | Frozen Sections - economics | Indoles - analysis | Humans | Molecular Imaging - economics | Fluorescent Dyes - analysis | Risk | Operative Time | Benzenesulfonates - analysis | Clinical Trials, Phase I as Topic - economics | Reoperation - statistics & numerical data | Female | Breast Neoplasms - diagnostic imaging | Reoperation - economics | Surgery, Computer-Assisted - economics | Bevacizumab - analysis | Breast Neoplasms - epidemiology | Mastectomy, Segmental - economics | Models, Theoretical | Health Expenditures - statistics & numerical data | Decision Support Techniques | Margins of Excision | Surgery, Computer-Assisted - methods | Germany - epidemiology | Health Care Costs - statistics & numerical data | Optical Imaging - economics | Medical research | Surgery | Breast | Medicine, Experimental | Diagnostic imaging | Comparative analysis | Cost benefit analysis | Nuclear medicine | Costs | Fluorescence | Confidence intervals | Reduction | Health economics | Mathematical models | Vascular endothelial growth factor | Lymphatic system | Medical imaging | Environmental health | Health risks | Breast cancer | Decision analysis | Molecular chains | Cost control | Cancer surgery | Pathology | Surgeons | Tornadoes | Cost analysis | Methods | Cancer | Tumors
Journal Article
Value in Health, ISSN 1098-3015, 2011, Volume 14, Issue 6, pp. 846 - 851
Journal Article
Journal Article
Journal of Managed Care Pharmacy, ISSN 1083-4087, 2006, Volume 12, Issue 7, pp. 570 - 577
Journal Article
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, ISSN 0820-3946, 09/2012, Volume 184, Issue 12, pp. E635 - 636
Journal Article
Journal Article
Journal Article
Alimentary pharmacology & therapeutics, ISSN 1365-2036, 2010, Volume 31, Issue 4, pp. 461 - 476
Aliment Pharmacol Ther 31, 461–476 Summary Background  Hepatocellular carcinoma is the leading cause of death in cirrhosis. A majority of patients present at... 
DRUG ELUTING BEADS | UNITED-STATES | RISK-FACTORS | PORTAL-VEIN THROMBOSIS | CHRONIC LIVER-DISEASE | ETHANOL INJECTION | PHARMACOLOGY & PHARMACY | CIRRHOTIC-PATIENTS | RANDOMIZED CONTROLLED-TRIAL | GASTROENTEROLOGY & HEPATOLOGY | HEPATITIS-C | RADIOFREQUENCY ABLATION | Recurrence | United States - epidemiology | Humans | Middle Aged | Liver Cirrhosis - mortality | Ablation Techniques | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Benzenesulfonates - adverse effects | Incidence | Young Adult | Liver Neoplasms - epidemiology | Benzenesulfonates - pharmacology | Pyridines - adverse effects | Hepatitis C, Chronic - epidemiology | Carcinoma, Hepatocellular - diagnosis | Liver Cirrhosis - complications | Chemoembolization, Therapeutic | Risk Factors | Survival Rate | Antineoplastic Agents - economics | Contrast Media | Neovascularization, Pathologic - drug therapy | Quality of Life | African Continental Ancestry Group | Population Surveillance | Practice Guidelines as Topic | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - epidemiology | Liver Transplantation | Benzenesulfonates - therapeutic use | Drug Eruptions - prevention & control | Liver Neoplasms - therapy | Phenylurea Compounds | Hepatitis C, Chronic - complications | Neoplasm Staging - methods | Antineoplastic Agents - adverse effects | Adult | Female | Antineoplastic Agents - pharmacology | Pyridines - therapeutic use | Hepatitis B, Chronic - epidemiology | Treatment Outcome | Randomized Controlled Trials as Topic | Asian Continental Ancestry Group | Health Care Costs | Hepatitis B, Chronic - complications | Liver Neoplasms - diagnosis | Biopsy | Carcinoma, Hepatocellular - therapy | Pyridines - pharmacology | Strategic planning (Business) | Liver cancer | Algorithms | Hepatoma
Journal Article